Cargando…
The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas
To investigate the association between widespread use of mifepristone in abortions and risk of uterine leiomyomas. We conducted a case-control study of 305 patients with uterine leiomyomas between January 2011 and July 2012; 311 women with ordinary vaginitis were selected as controls during the same...
Autores principales: | Shen, Qi, Shu, Li, Luo, Hui, Hu, Xiaoli, Zhu, Xueqiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413233/ https://www.ncbi.nlm.nih.gov/pubmed/28445268 http://dx.doi.org/10.1097/MD.0000000000006680 |
Ejemplares similares
-
Long-term use of ultra-low-dose mifepristone for uterine leiomyoma control and safety discussion: A case report
por: Zhou, Guangdi, et al.
Publicado: (2022) -
The efficacy and influence factors analysis of Mifepristone combined with estrogen-progesterone in the treatment of incomplete abortion
por: Wang, Kai, et al.
Publicado: (2022) -
Mifepristone inhibits IGF-1 signaling pathway in the treatment of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2019) -
Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial
por: Liu, Chongdong, et al.
Publicado: (2017) -
Uterine leiomyoma with fumarate hydratase deficiency: A case report
por: Huang, Yan, et al.
Publicado: (2021)